Diagnostic Workup for Hemochromatosis
The recommended workup for hemochromatosis follows a three-step algorithm: initial serologic testing with transferrin saturation and serum ferritin, followed by genetic testing, and in select cases, liver biopsy to assess for fibrosis or cirrhosis. 1
Step 1: Initial Serologic Testing
Fasting transferrin saturation (TS) - primary screening test
Serum ferritin - should be measured simultaneously
Complete blood count with reticulocytes - to exclude anemia and red cell disorders 1
Step 2: Genetic Testing
If transferrin saturation and ferritin are elevated:
HFE gene mutation analysis for:
- C282Y homozygosity (most common cause)
- C282Y/H63D compound heterozygosity
- H63D homozygosity 1
In patients of non-European origin with clinical suspicion and elevated iron studies:
- Consider direct sequencing of multiple genes (HFE, HJV, TFR2, CP, SLC40A1) 1
Step 3: Assessment for End-Organ Damage
Liver Assessment:
Non-invasive fibrosis assessment:
Liver biopsy indicated in:
Cardiac Assessment:
- ECG and echocardiography for patients with severe iron overload 1
- Cardiac MRI for iron quantification in:
Other Assessments:
- Joint evaluation - particularly ankles, hips, hands/wrists 1
- Endocrine evaluation - glucose tolerance test if diabetes suspected 1
Special Considerations
Family Screening
- First-degree relatives of patients with HFE-related hemochromatosis should undergo:
- Serum ferritin and transferrin saturation testing
- HFE mutation analysis 1
Common Pitfalls to Avoid
Misinterpreting hyperferritinemia - Always rule out common causes before genetic testing:
Relying solely on genetic testing - Diagnosis requires both genetic predisposition AND evidence of increased iron stores 1
Missing non-HFE hemochromatosis - Rare forms due to mutations in other genes (HAMP, HJV, TFR2, SLC40A1) should be considered in patients with iron overload but negative HFE testing 3
Overlooking the need for liver biopsy - Essential in patients with ferritin >1,000 μg/L to assess for cirrhosis, which significantly impacts prognosis and management 1
Early diagnosis and treatment with phlebotomy can prevent serious complications including cirrhosis, hepatocellular carcinoma, diabetes, arthropathy, and cardiac disease, significantly improving morbidity, mortality, and quality of life 1, 4.